Nintedanib slows loss of lung function in limited cutaneous systemic sclerosis, ILD healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
-Interim results of largest real-world study of TRIKAFTA® showed sustained improvement in lung function, reduction in pulmonary exacerbations frequency and lower rates of lung transplant and. | June 9, 2023
-Interim results of largest real-world study of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) showed sustained improvement in lung function, reduction in pulmonary exacerbations frequency
-Interim results of largest real-world study of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) showed sustained improvement in lung function, reduction in pulmonary exacerbations frequency and lower rates of lung transplant and death for people with cystic fibrosis Twelve presentations add to the body.
EULAR has launched RheumaFacts, a novel resource for local and national data regarding rheumatic and musculoskeletal diseases in Europe, according to a presenter at the EULAR 2023 Congress.